- Home
- CURV vs TARS Comparison
CURV vs TARS Comparison
Compare CURV & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CURV
- TARS
- Stock Information
- Founded
- CURV 2001
- TARS 2016
- Country
- CURV United States
- TARS United States
- Employees
- CURV N/A
- TARS N/A
- Industry
- CURV Clothing/Shoe/Accessory Stores
- TARS Medicinal Chemicals and Botanical Products
- Sector
- CURV Consumer Discretionary
- TARS Health Care
- Exchange
- CURV Nasdaq
- TARS Nasdaq
- Market Cap
- CURV 914.1M
- TARS 1.0B
- IPO Year
- CURV 2021
- TARS 2020
- Fundamental
- Price
- CURV $6.99
- TARS $30.59
- Analyst Decision
- CURV Hold
- TARS Strong Buy
- Analyst Count
- CURV 6
- TARS 6
- Target Price
- CURV $4.96
- TARS $51.17
- AVG Volume (30 Days)
- CURV 328.0K
- TARS 822.5K
- Earning Date
- CURV 09-04-2024
- TARS 08-08-2024
- Dividend Yield
- CURV N/A
- TARS N/A
- EPS Growth
- CURV N/A
- TARS N/A
- EPS
- CURV 0.13
- TARS N/A
- Revenue
- CURV $1,133,356,000.00
- TARS $83,374,000.00
- Revenue This Year
- CURV $1.57
- TARS $846.12
- Revenue Next Year
- CURV $1.54
- TARS $70.19
- P/E Ratio
- CURV $50.14
- TARS N/A
- Revenue Growth
- CURV N/A
- TARS 566.99
- 52 Week Low
- CURV $1.21
- TARS $12.57
- 52 Week High
- CURV $9.14
- TARS $42.50
- Technical
- Relative Strength Index (RSI)
- CURV 50.37
- TARS 62.36
- Support Level
- CURV $5.94
- TARS $25.82
- Resistance Level
- CURV $7.14
- TARS $29.50
- Average True Range (ATR)
- CURV 0.76
- TARS 1.67
- MACD
- CURV 0.02
- TARS 0.41
- Stochastic Oscillator
- CURV 85.71
- TARS 89.79
About CURV Torrid Holdings Inc.
Torrid Holdings Inc is a direct-to-consumer brand of apparel, intimates, and accessories in North America targeting 27 to 42-year-old women. It is focused on fit and offers high-quality products across a broad assortment that includes tops, bottoms, denim, dresses, intimates, activewear, footwear, and accessories. The company has one reportable segment, which includes the operation of e-Commerce platform and stores.
About TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.